itvisma
(Onasemnogene Abeparvovec-Brve)Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. drugs
2 results
zolgensma - onasemnogene abeparvovec - xioi
(Onasemnogene Abeparvovec-Xioi)Novartis Gene Therapies, Inc.Usage: Zolgensma is a gene therapy for pediatric patients under 2 years old with spinal muscular atrophy (SMA) caused by bi-allelic mutations in the SMN1 gene.